Cabaron, Jenelyn B.
HRN: 22-62-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
04/01/2023
04/01/2023
ORAL
25 ML
Single Dose
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes